EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Serum Angiopoietin-1 and Angiopoietin-2 as Biomarkers of Pulmonary Hemodynamic Burden in COPD-Associated Pulmonary Hypertension: A Cross-Sectional Study

Jyoti Bajpai iD, Akshyaya Pradhan iD, Mohammed Kaleem Ahmad, Surya Kant iD, Ajay Kumar Verma iD, Darshan Kumar Bajaj, Rishi Sethi, Mario Cazzola iD

Advances in Respiratory Medicine · 11.08.2026 · 94 (4) · 59

DOI: 10.3390/arm94040059 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Advances in Respiratory Medicine, online erschienen am 11.08.2026. Verfasst von Jyoti Bajpai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, KGMU, U.P., Lucknow 226003, India. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Hypertension, Pulmonary, Angiopoietin-1, Angiopoietin-2. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Pulmonary hypertension (PH) is a serious complication of COPD associated with worse outcomes. Reliable circulating biomarkers of pulmonary vascular involvement are lacking. Angiopoietin-1 (ANGP-1) and angiopoietin-2 (ANGP-2) regulate endothelial homeostasis, but their relationship with echocardiographically estimated pulmonary pressure in COPD remains uncertain.

Methods

This prospective cross-sectional study included 70 consecutively recruited adults with COPD, stratified using a study-specific echocardiographic threshold into the COPD PH group (mPAP > 20 mmHg; n = 46) and the COPD without PH (mPAP < 20 mmHg; n = 24), together with 20 additional controls. This non-invasive stratification was not considered equivalent to PH confirmed by right heart catheterization. Serum ANGP-1 and ANGP-2 were measured using ELISA. Group differences and associations with e-mPAP and right atrial pressure (RAP) were assessed.

Results

Median ANGP-1 was higher in the elevated e-mPAP group [8780.06 (IQR 7955.29–9902.88) pg/mL] than in the lower e-mPAP group [3065.14 (1170.69–6200.41)] and controls [2997.19 (1292.13–3278.18); p < 0.001]. ANGP-2 showed a similar pattern [6152.92 (5380.27–8652.50), 2669.77 (1802.18–4744.00), and 2405.54 (1779.73–3751.76) pg/mL; p < 0.001]. Among COPD participants, ANGP-1 and ANGP-2 correlated with e-mPAP (r = 0.64 and r = 0.54) and RAP (r = 0.54 and r = 0.52; all Holm-adjusted p < 0.001). In multivariable models, e-mPAP and RAP were independently associated with ANGP-1, whereas RAP was independently associated with ANGP-2.

Conclusions

Higher circulating ANGP-1 and ANGP-2 were associated with an elevated echo-estimated pulmonary-pressure phenotype in COPD. These findings are exploratory and require validation in larger cohorts using direct hemodynamic assessment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveHypertension, PulmonaryAngiopoietin-1Angiopoietin-2HumansCross-Sectional StudiesBiomarkersFemaleMaleProspective StudiesAgedMiddle AgedHemodynamics

Stichwörter der Autor:innen

angiopoietin-1angiopoietin-2biomarkerschronic obstructive pulmonary diseaseechocardiographynon-invasive assessmentpulmonary hypertensionvascular remodeling

Substanzen

BiomarkersAngiopoietin-1Angiopoietin-2

Autor:innen und Institutionen

  • Department of Respiratory Medicine, KGMU, U.P., Lucknow 226003, India.
  • Department of Cardiology, KGMU, U.P., Lucknow 226003, India.
  • Department of Biochemistry, KGMU, U.P., Lucknow 226003, India.
  • Department of Respiratory Medicine, RML Institute of Medical Sciences, Lucknow 226010, India.
  • Dipartimento di Medicina dei Sistemi, University of Rome Tor Vergata, 00133 Rome, Italy.

ORCID-Profile: Jyoti Bajpai, Akshyaya Pradhan, Surya Kant, Ajay Kumar Verma, Mario Cazzola

Zitieren

APA

Bajpai, J., Pradhan, A., Ahmad, M. K., Kant, S., Verma, A. K., Bajaj, D. K., Sethi, R., & Cazzola, M. (2026). Serum Angiopoietin-1 and Angiopoietin-2 as Biomarkers of Pulmonary Hemodynamic Burden in COPD-Associated Pulmonary Hypertension: A Cross-Sectional Study. Advances in Respiratory Medicine, 94(4), 59. https://doi.org/10.3390/arm94040059

Vancouver

Bajpai J, Pradhan A, Ahmad MK, Kant S, Verma AK, Bajaj DK, et al. Serum Angiopoietin-1 and Angiopoietin-2 as Biomarkers of Pulmonary Hemodynamic Burden in COPD-Associated Pulmonary Hypertension: A Cross-Sectional Study. Advances in Respiratory Medicine. 2026;94(4):59. doi:10.3390/arm94040059

BibTeX
@article{Bajpai2026,
  author = {Bajpai, Jyoti and Pradhan, Akshyaya and Ahmad, Mohammed Kaleem and Kant, Surya and Verma, Ajay Kumar and Bajaj, Darshan Kumar and Sethi, Rishi and Cazzola, Mario},
  title = {Serum Angiopoietin-1 and Angiopoietin-2 as Biomarkers of Pulmonary Hemodynamic Burden in COPD-Associated Pulmonary Hypertension: A Cross-Sectional Study},
  journal = {Advances in Respiratory Medicine},
  year = {2026},
  volume = {94},
  number = {4},
  pages = {59},
  doi = {10.3390/arm94040059}
}
Kostenlos starten →